CLevel Interviews Confirm Allogene (ALLO) Best Positioned Among Next Gen Cell Therapies - Piper Jaffray
Go back to CLevel Interviews Confirm Allogene (ALLO) Best Positioned Among Next Gen Cell Therapies - Piper Jaffray| (NASDAQ: ALLO) | Delayed: 2.02 +0.04 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.98 | 52 Week High | $ | |||
| Open | $1.96 | 52 Week Low | $ | |||
| Day High | $2.04 | P/E | N/A | |||
| Day Low | $1.92 | EPS | $ | |||
| Volume | 2,591,962 | |||||

